0.55% 0.075

Amphastar Pharmaceuticals Inc (AMPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AMPH? Forum Prognose

Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.55% 183.10	191.84	174.41	170.53	191.21
Cost Of Revenue	4.55% 97.44	93.19	87.92	85.28	89.27
Gross Profit	13.15% 85.67	98.65	86.49	85.25	101.94
Operating Expenses	31.72% 50.06	73.33	44.31	47.96	44.89
Benefits Costs and Expenses	11.23% 151.19	170.33	135.08	139.67	143.53
Costs And Expenses	11.23% 151.19	170.33	135.08	139.67	143.53
Operating Income/Loss	40.62% 35.61	25.32	42.18	37.29	57.05
Nonoperating Income/Loss	3.02% -3.692	-3.807	-2.849	-6.431	-9.365
Income/Loss From Continuing Operations Before Tax	48.35% 31.91	21.51	39.34	30.86	47.68
Income Tax Expense/Benefit	79.80% 7.485	4.163	8.305	5.577	7.254
Income/Loss From Continuing Operations After Tax	40.80% 24.43	17.35	31.03	25.29	40.43
Net Income/Loss	40.80% 24.43	17.35	31.03	25.29	40.43
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.60% -0.278	46.47	46.95	47.64	48.62
Diluted Average Shares	100.73% -0.35	47.68	48.13	49.89	51.86
Basic Earnings Per Share	39.47% 0.53	0.38	0.66	0.53	0.83
Diluted Earnings Per Share	37.84% 0.51	0.37	0.64	0.51	0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.78

0.67%

RGC

$23.30

0.00%

RDY

$14.21

0.93%

NBIX

$130.01

1.75%

VTRS

$13.86

0.90%

UTHR

$537.49

1.12%